| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Edward L Cahill is Director at PHR and has filed Form 4s across 2 companies. Edward L Cahill's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $906K at current prices.
Historically, Edward L Cahill's trades have earned a middling insider score of 59/100 across 3 rated trades. Over a 12-month horizon, all 3 of those trades were profitable, with an average 12-month return of +57.0%.
The biggest single holding is PHR (~$802K) as Director. The PHR filings lean toward selling, a net 78,450 shares.
Edward L Cahill has 46 Form 4 filings on record from November 2015 to April 2026, across 2 companies: Director at Phreesia (PHR), 2020–2026; Director at Tandem Diabetes Care (TNDM), 2015–2020.
The 67 reported transactions were 27 stock awards, 20 other transactions, 11 open-market sales and 7 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 7 sales worth about $4.5M.
The largest open-market sale was 24,370 shares of PHR at an average $57.22 on December 24, 2020, about $1.4M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2021 | PHR Phreesia, Inc. | Director | Sell | 5,000 | $60.03 | $300,149.00 | -16.2% | +11.1% | -55.6% | |
| Jun 14, 2021 | PHR Phreesia, Inc. | Director | Sell | 15,000 | $57.47 | $862,037.74 | -32.7% | +20.4% | -70.0% | |
| Apr 1, 2021 | PHR Phreesia, Inc. | Director | Sell | 15,000 | $54.94 | $824,115.28 | -24.7% | +11.2% | -45.5% | |
| Feb 18, 2021 | PHR Phreesia, Inc. | Director | Sell | 10,000 | $72.00 | $720,026.38 | -14.1% | - | - | |
| Dec 24, 2020 | PHR Phreesia, Inc. | Director | Sell | 24,370 | $57.22 | $1,394,480.64 | -25.6% | - | - | |
| Jul 21, 2020 | PHR Phreesia, Inc. | Director | Sell | 9,080 | $29.02 | $263,519.76 | -16.3% | - | - | |
| Aug 13, 2019 | TNDM Tandem Diabetes Care Inc | Director | Sale+OE | 1,417 | $63.03 | $89,313.51 | -26.2% | - | - |